How I treat autoimmune hemolytic anemias in adults
- 16 September 2010
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 116 (11), 1831-1838
- https://doi.org/10.1182/blood-2010-03-259325
Abstract
Autoimmune hemolytic anemia is a heterogeneous disease with respect to the type of the antibody involved and the absence or presence of an underlying condition. Treatment decisions should be based on careful diagnostic evaluation. Primary warm antibody autoimmune hemolytic anemias respond well to steroids, but most patients remain steroid-dependent, and many require second-line treatment. Currently, splenectomy can be regarded as the most effective and best-evaluated second-line therapy, but there are still only limited data on long-term efficacy and adverse effects. The monoclonal anti-CD20 antibody rituximab is another second-line therapy with documented short-term efficacy, but there is limited information on long-term efficacy and side effects. The efficacy of immunosuppressants is poorly evaluated. Primary cold antibody autoimmune hemolytic anemias respond well to rituximab but are resistant to steroids and splenectomy. The most common causes of secondary autoimmune hemolytic anemias are malignancies, immune diseases, or drugs. They may be treated in a way similar to primary autoimmune hemolytic anemias, by immunosuppressants or by treatment of the underlying disease.Keywords
This publication has 87 references indexed in Scilit:
- Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studiesVaccine, 2010
- The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction?Transfusion Medicine, 2008
- Cold antibody autoimmune hemolytic anemiasBlood Reviews, 2008
- Hemolytic anemia due to warm autoantibodiesBlood Reviews, 2008
- Management of cold haemolytic syndromeBritish Journal of Haematology, 2007
- Epidemiology of autoimmune diseases in DenmarkJournal of Autoimmunity, 2007
- Treatment of Autoimmune Hemolytic AnemiaSeminars in Hematology, 2005
- Autoimmune hemolytic anemiaAmerican Journal of Hematology, 2002
- The immune haemolytic anaemias: a century of exciting progress in understandingBritish Journal of Haematology, 2001
- Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre.BMJ, 1981